Pliant Therapeutics Inc.
PLRX | NASDAQ
$0.86
$0.00 (0.00%)
At close: Oct 30, 2026, 4:00 PM ET
$0.85
-$0.01 (-1.16%)
After-hours:
Oct 30, 2026, 6:44 PM ET
+0.00%
(1D)No price chart data available for 1D timeframe.
Rating
34
+3.0 ptsFundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #684/1028 (Top 67%)
Key Statistics
Market Data
Market Cap $53.18M
1D Range
0.84 0.86
52W Range
0.84 1.80
Valuation (TTM)
PE -0.58
PB 0.36
EV/EBITDA 0.86
Valuation (NTM)
Forward PE N/A
Forward PEG 0.01
Price Target $25.86
Cash Flow
FCF Yield -133.3%
SBC Adj. FCF Yield -169.8%
SBC Impact -27.3%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y -150.0% |
-83.1%
Dil EPS 3Y | 5Y 30.1% |
8.0%
FCF 3Y | 5Y 27.1% |
-2.4%
Returns
ROA -48.6%
ROE -53.2%
ROIC -55.5%
Financial Health
Net Cash
$158.1M
Current Ratio 9.90
Interest Coverage -102.50
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Pliant Therapeutics, Inc. is a biopharmaceutical company in the clinical development stage, dedicated to discovering, advancing, and bringing to market innovative therapies for fibrotic and related di...
Sector Healthcare
Industry Biotechnology
Employees 49
IPO Date Jun 3, 2020
Website pliantrx.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
3
Consensus
Hold
Price Target
$38.00
Upside
+4318.60%
Buy (1)
Hold (2)
Sell (0)
Add to Watchlist
Select watchlists to add or remove PLRX